|
HY-121532-500ug
|
MedChemexpress LLC
|
(-)-Rasfonin [CAS 303156-68-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-N2540-1mg
|
MedChemexpress LLC
|
(�)-Pinocembrin [CAS 68745-38-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-N2540-10mg
|
MedChemexpress LLC
|
(�)-Pinocembrin [CAS 68745-38-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-N2540-5mg
|
MedChemexpress LLC
|
(�)-Pinocembrin [CAS 68745-38-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-N0060B-100mg
|
MedChemexpress LLC
|
(E)-Ferulic acid [CAS 537-98-4]
|
|
Cancer-Kinase/protease
|
|
|
HY-N0060B-1mL
|
MedChemexpress LLC
|
(E)-Ferulic acid [CAS 537-98-4] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
HY-N0060BS-1mg
|
MedChemexpress LLC
|
(E)-Ferulic acid-d3 [CAS 860605-59-0]
|
|
|
|
|
HY-N0060BS-5mg
|
MedChemexpress LLC
|
(E)-Ferulic acid-d3 [CAS 860605-59-0]
|
|
|
|
|
HY-122751-10mg
|
MedChemexpress LLC
|
(R)-DNMDP [CAS 1630760-60-9]
|
|
Cancer-programmed cell death
|
|
|
HY-122751-100mg
|
MedChemexpress LLC
|
(R)-DNMDP [CAS 1630760-60-9]
|
|
Cancer-programmed cell death
|
|
|
HY-122751-5mg
|
MedChemexpress LLC
|
(R)-DNMDP [CAS 1630760-60-9]
|
|
Cancer-programmed cell death
|
|
|
HY-122751-50mg
|
MedChemexpress LLC
|
(R)-DNMDP [CAS 1630760-60-9]
|
|
Cancer-programmed cell death
|
|
|
HY-122751-1mL
|
MedChemexpress LLC
|
(R)-DNMDP [CAS 1630760-60-9] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-N0448-10mg
|
MedChemexpress LLC
|
10-Gingerol [CAS 23513-15-7]
|
|
Cancer-programmed cell death
|
|
|
HY-N0448-20mg
|
MedChemexpress LLC
|
10-Gingerol [CAS 23513-15-7]
|
|
Cancer-programmed cell death
|
|
|
HY-N0448-5mg
|
MedChemexpress LLC
|
10-Gingerol [CAS 23513-15-7]
|
|
Cancer-programmed cell death
|
|
|
HY-N0448-1mL
|
MedChemexpress LLC
|
10-Gingerol [CAS 23513-15-7] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-138822-10mg
|
MedChemexpress LLC
|
2,3-Diphospho-D-glyceric acid (pentasodium salt) [CAS 102783-53-9]
|
|
|
|
|
HY-138822-5mg
|
MedChemexpress LLC
|
2,3-Diphospho-D-glyceric acid (pentasodium salt) [CAS 102783-53-9]
|
|
|
|
|
HY-131688-1mg
|
MedChemexpress LLC
|
2-Chlorohexadecanoic acid [CAS 19117-92-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-12033-10mg
|
MedChemexpress LLC
|
2-Methoxyestradiol [CAS 362-07-2]
|
|
Cancer-programmed cell death
|
|
|
HY-12033-100mg
|
MedChemexpress LLC
|
2-Methoxyestradiol [CAS 362-07-2]
|
|
Cancer-programmed cell death
|
|
|
HY-12033-5mg
|
MedChemexpress LLC
|
2-Methoxyestradiol [CAS 362-07-2]
|
|
Cancer-programmed cell death
|
|
|
HY-12033-50mg
|
MedChemexpress LLC
|
2-Methoxyestradiol [CAS 362-07-2]
|
|
Cancer-programmed cell death
|
|
|
HY-12033-1mL
|
MedChemexpress LLC
|
2-Methoxyestradiol [CAS 362-07-2] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
